InvestorsHub Logo
icon url

Jimmy Joe

09/10/15 2:41 PM

#164612 RE: WeeZuhl #164607

Patients who snorted the ELI-200 thought they were snorting the placebo. Nice.

icon url

YJ4LIFE

09/10/15 2:46 PM

#164614 RE: WeeZuhl #164607

Thanks WeeZuhl for the explaination! Great R&R!
icon url

John_Langston

09/10/15 9:13 PM

#164653 RE: WeeZuhl #164607

I liked the one about the 15 solvents; nasRAT said after testing with the 15 solvents the product was Chewing proof; snorting proof and smoking proof but he said nothing about separation proof. When the two beads are found to be easily separated the Elite tech will be done.
icon url

dr_lowenstein

09/11/15 12:13 PM

#164720 RE: WeeZuhl #164607

I am surprised by your response. As you know, the half life of naloxone or naltrexone is largely irrelevant as these substances only come into play when abuse is undertaken and then the half life of such is not the same as the GI half life of the drugs if taken via oral administration. Further, as you know, in the case of Targiniq, the bioavailability after oral administration of noloxone is negligible, ie less than 2% by design. Thus I must conclude that such arguments are mere red herrings